TLDRocket
Sign in

Adebayo Alonge

Person Covered in 1 story + Follow ✴ AI Graph Request update Wikipedia

Adebayo Alonge is a Nigerian pharmacist, inventor, and deep tech entrepreneur focused on counterfeit drug detection technology. He created a handheld nanoscanner capable of identifying fake pharmaceuticals, an innovation that earned him the 2019 Hello Tomorrow Global Deeptech Challenge award, also known as the BNP Paribas Group Deep Tech Award. His work has been cited as an example of small, low-power AI models being adopted in developing countries for applications such as counterfeit drug detection. Alonge's career spans pharmacy practice and market development, with his technology positioned at the intersection of public health and deep tech innovation.

Updated 6 August 2026

Public sources: Wikipedia

Why this page exists, and how to correct or remove it

This profile is assembled automatically because Adebayo Alonge appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.

We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.

Claim or correct this profile Request removal How we handle personal data

Signals

Media momentum

As of 17 Sep 2026 · Visible stories in the last 30 days, compared with the 30 days before.

1 source

Source diversity

As of 17 Sep 2026 · Distinct publications behind this entity's visible coverage.

Jul 2026

Coverage span

As of 17 Sep 2026 · First to most recent month of TLDRocket coverage of this entity.

Latest developments

Timeline

Month Quarter Year

Q3 2026

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.